LDC-backed Agentis Health Group launches with acquisition of Living With
LDC-backed Agentis Health Group (AHG), a UK-based digital health management specialist, launches with the acquisition of Living With, a leading digital health company specialising in condition-specific therapeutics and remote patient assessment, management and rehabilitation. This marks AHG’s first strategic move in bringing together the critical services needed to strengthen its digital therapeutics offer and transform long-term condition management for the NHS.
Established from within Ashtons – a leading UK provider of medicines management and prescribing technologies – AHG has been created to deliver better health outcomes for people living with long-term conditions. It will encompass three core service areas: Agentis Healthcare, Agentis Therapeutics and Agentis Diagnostics. Living With, along with Ashtons Virtual Hub and Primary Care Services, will sit within Agentis Healthcare.
With a focus on chronic conditions relevant to NHS primary care, such as heart failure, COPD and diabetes, AHG brings together a unique blend of expertise across clinical and digital excellence, therapeutics and healthcare management, medicines management and diagnostics. With the offer of managing long-term condition pathways end-to-end, AHG is building a single, scalable platform designed to help the NHS deliver smarter, more joined-up care.
PMSI provided CDD to support the acquisition, addressing key investment themes including: a detailed sizing of Living With’s addressable market and its alignment with the NHS’ long-term strategy; understanding the increasing shift towards digital management of long-term conditions; and an in-depth customer referencing process.
Read more